BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38079581)

  • 1. Cerebrospinal fluid CXCL13 concentration for diagnosis and monitoring of neurosyphilis in people with HIV.
    Carvalho RS; Rangel IC; Soane MM; Bacarov NBS; Herbst V; Ferry FRA
    AIDS; 2024 Apr; 38(5):657-668. PubMed ID: 38079581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of CXCL13 in diagnosing asymptomatic neurosyphilis in HIV-infected patients.
    Hu R; Lu C; Lu S; Hu Y; Ma H; Lai W; Zhu G; Feng P; Lu R; Li Y
    Int J STD AIDS; 2016 Feb; 27(2):141-6. PubMed ID: 25769888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCL13 as a cerebrospinal fluid marker for neurosyphilis in HIV-infected patients with syphilis.
    Marra CM; Tantalo LC; Sahi SK; Maxwell CL; Lukehart SA
    Sex Transm Dis; 2010 May; 37(5):283-7. PubMed ID: 20393380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of
    Yang L; Fu Y; Li S; Liu C; Liu D
    Infect Drug Resist; 2022; 15():7791-7798. PubMed ID: 36600952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical prediction and diagnosis of neurosyphilis in HIV-infected patients with early Syphilis.
    Dumaresq J; Langevin S; Gagnon S; Serhir B; Deligne B; Tremblay C; Tsang RS; Fortin C; Coutlée F; Roger M
    J Clin Microbiol; 2013 Dec; 51(12):4060-6. PubMed ID: 24088852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Has CXCL13 an added value in diagnosis of neurosyphilis?
    Mothapo KM; Verbeek MM; van der Velden LB; Ang CW; Koopmans PP; van der Ven A; Stelma F
    J Clin Microbiol; 2015 May; 53(5):1693-6. PubMed ID: 25788544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternatives to the Cerebrospinal Fluid Venereal Disease Research Laboratory Test for Neurosyphilis Diagnosis.
    Marra CM
    Sex Transm Dis; 2021 Aug; 48(8S):S54-S57. PubMed ID: 33967236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid treponemal antibodies in untreated early syphilis.
    Marra CM; Critchlow CW; Hook EW; Collier AC; Lukehart SA
    Arch Neurol; 1995 Jan; 52(1):68-72. PubMed ID: 7826278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCL13 and TH1/Th2 cytokines in the serum and cerebrospinal fluid of neurosyphilis patients.
    Yan Y; Wang J; Qu B; Zhang Y; Wei Y; Liu H; Wu C
    Medicine (Baltimore); 2017 Nov; 96(47):e8850. PubMed ID: 29381995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid human immunodeficiency virus viral load in patients with neurosyphilis.
    de Almeida SM; Bhatt A; Riggs PK; Durelle J; Lazzaretto D; Marquie-Beck J; McCutchan A; Letendre S; Ellis R
    J Neurovirol; 2010 Feb; 16(1):6-12. PubMed ID: 20132081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal Fluid Treponema pallidum Particle Agglutination Assay for Neurosyphilis Diagnosis.
    Marra CM; Maxwell CL; Dunaway SB; Sahi SK; Tantalo LC
    J Clin Microbiol; 2017 Jun; 55(6):1865-1870. PubMed ID: 28381602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment.
    Lukehart SA; Hook EW; Baker-Zander SA; Collier AC; Critchlow CW; Handsfield HH
    Ann Intern Med; 1988 Dec; 109(11):855-62. PubMed ID: 3056164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCL13 chemokine as a promising biomarker to diagnose neurosyphilis in HIV-negative patients.
    Zeng YL; Lin YQ; Zhang NN; Zou CN; Zhang HL; Peng F; Liu ZJ; Zheng WH; Yan JH; Liu LL
    Springerplus; 2016; 5(1):743. PubMed ID: 27376011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL13, CXCL10 and CXCL8 as Potential Biomarkers for the Diagnosis of Neurosyphilis Patients.
    Wang C; Wu K; Yu Q; Zhang S; Gao Z; Liu Y; Ni L; Cheng Y; Guan Z; Shi M; Lu H; Lou Y; Zhou P
    Sci Rep; 2016 Sep; 6():33569. PubMed ID: 27650493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic role of CXCL13 and CSF serology in patients with neurosyphilis.
    Li D; Huang X; Shi M; Luo L; Tao C
    Sex Transm Infect; 2021 Nov; 97(7):485-489. PubMed ID: 33436504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How Well Do Neurologic Symptoms Identify Individuals With Neurosyphilis?
    Davis AP; Stern J; Tantalo L; Sahi S; Holte S; Dunaway S; Marra CM
    Clin Infect Dis; 2018 Jan; 66(3):363-367. PubMed ID: 29020214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative cerebrospinal fluid tests to diagnose neurosyphilis in HIV-infected individuals.
    Marra CM; Tantalo LC; Maxwell CL; Dougherty K; Wood B
    Neurology; 2004 Jul; 63(1):85-8. PubMed ID: 15249615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokine Ligand 13 (CXCL13) in Neuroborreliosis and Neurosyphilis as Selected Spirochetal Neurological Diseases: A Review of Its Diagnostic Significance.
    Gudowska-Sawczuk M; Mroczko B
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid CXCL13 concentration for diagnosis of neurosyphilis: a systematic review and meta-analysis.
    Du FZ; Zhang X; Zheng XL; Zhang RL; Wang QQ
    BMJ Open; 2024 May; 14(5):e078527. PubMed ID: 38821573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of neurosyphilis in human immunodeficiency virus-infected patients with latent syphilis.
    Holtom PD; Larsen RA; Leal ME; Leedom JM
    Am J Med; 1992 Jul; 93(1):9-12. PubMed ID: 1626576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.